Illustration: Shoshana Gordon/Axios
It's been a quiet start to the year for the digital health sector. That's the takeaway after JPM and ViVE.
Why it matters: A business landscape once dotted with early-stage experiments has shifted to one dominated by a handful of massively well-funded bets.
